Venus Remedies secures marketing authorisations for oncology drugs from Morocco, Philippines

The approvals include bortezomib in the Philippines and carboplatin in Morocco

Venus Remedies has secured marketing authorizations for two key cancer drugs, enhancing its global reach. The approvals include bortezomib in the Philippines and carboplatin in Morocco, boosting the company’s oncology portfolio to 508 approvals across 76 countries.

Saransh Chaudhary, President of Global Critical Care, Venus Remedies, expressed, “These approvals are pivotal in our strategy to expand our oncology range and meet the increasing global demand for cancer treatments. We are advancing toward becoming the leading oncology supplier in Southeast Asia.”

Aditi K Chaudhary, President of International Business, emphasised the company’s role in supporting global health initiatives, stating, “These authorisations reflect our commitment to providing innovative and accessible healthcare solutions worldwide.”